home / stock / hbp:cc / hbp:cc news

HBP:CC News and Press, Helix BioPharma Corp. From 08/30/22

Stock Information
Company Name: Helix BioPharma Corp.
Stock Symbol: HBP:CC
Market: TSXC
Menu
HBP:CC HBP:CC Quote HBP:CC Short HBP:CC News HBP:CC Articles HBP:CC Message Board
Get HBP:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
HBP:CC - Helix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LP

(TheNewswire) Toronto, Ontario – TheNewswire – August 30, 2022 – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique therapies in the field of ...
HBP:CC - Helix BioPharma Corp. Announces Scientific Collaboration with University Hospital Tuebingen

(TheNewswire) Toronto, Ontario – TheNewswire – August 9, 2022 – Helix BioPharma Corp . (TSX:HBP) (OTC:HBPCF) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company that is developing unique th...

HBP:CC - Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.

VANCOUVER, BC / ACCESSWIRE / April 22, 2022 / Mr. Jerzy Wilczewski announces the acquisition of 7,700,000 common shares (" Common Shares ") in the capital of Helix Biopharma Corp. (" Helix " or the " Company ") (TSX: HBP ) at a price of $0.26 per Common Share by way of non-brokered privat...

HBP:CC - Helix Biopharma Corp. Closes Private Placement

RICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, today announces that ...
HBP:CC - Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members

RICHMOND HILL, ON / ACCESSWIRE / April 18, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platformDOS47, is pleased to announce...

HBP:CC - Helix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement Subscription

RICHMOND, ON / ACCESSWIRE / April 13, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, is pleased to announce tha...

HBP:CC - Helix Announces Board Resignation

RICHMOND HILL, ON / ACCESSWIRE / April 7, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, today announced the re...
HBP:CC - Helix Biopharma Corp. Announces Management and Board Changes

RICHMOND HILL, ON / ACCESSWIRE / March 22, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47, today announced that Fr...

HBP:CC - Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results

RICHMOND, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced fisc...

HBP:CC - Helix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the Board

RICHMOND HILL, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company") today announces, with great sadness, the sudden passing of its Interim Chief Executive Officer and Chairman of the Board of Directors (the "Board"), Prof. Dr. S Slawomir Majewski. Dr...
Previous 10 Next 10